Quent Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.87K Buy
21
+3
+17% +$369 ﹤0.01% 1431
2026
Q1
$2.12K Sell
18
-52
-74% -$7.26K ﹤0.01% 1386
2025
Q4
$11.5K Buy
70
+17
+32% +$2.66K ﹤0.01% 1122
2025
Q3
$7.08K Buy
+53
New +$6.44K ﹤0.01% 1083
2025
Q2
Sell
-30
Closed -$3.82K 1030
2025
Q1
$3.82K Hold
30
﹤0.01% 1059
2024
Q4
$4.32K Buy
30
+7
+30% +$1K ﹤0.01% 1071
2024
Q3
$3.36K Hold
23
﹤0.01% 1170
2024
Q2
$2.9K Buy
23
+21
+1,050% +$3.29K ﹤0.01% 1171
2024
Q1
$368 Buy
2
+1
+100% +$190 ﹤0.01% 1322
2023
Q4
$180 Buy
+1
New +$156 ﹤0.01% 1308

Other funds holding RGEN

Quent Capital's RGEN Position: Q2 2026 in Review

Quent Capital increased its Repligen (RGEN) stake by 17% in Q2 2026, buying an estimated $369 and bringing the position to 21 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1431.

Quent Capital first reported a position in RGEN in Q4 2023 and has held it in 10 quarters since. The position peaked at $11.5K in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Quent Capital held 21 shares of Repligen worth $2.87K as of Q2 2026.
  • Quent Capital bought 3 Repligen shares in Q2 2026, an estimated $369.
  • Repligen made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1431 holding.
  • Quent Capital first reported a position in Repligen in Q4 2023 and has held it in 10 quarters since.
  • Quent Capital's Repligen position peaked at $11.5K in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.